Table of Contents Author Guidelines Submit a Manuscript
Cholesterol
Volume 2013 (2013), Article ID 891403, 18 pages
http://dx.doi.org/10.1155/2013/891403
Review Article

HDL, Atherosclerosis, and Emerging Therapies

1McGill University, Montreal, QC, Canada H3A 1A1
2Faculty of Medicine, Center for Innovative Medicine, McGill University Health Center, Royal Victoria Hospital, McGill University, 687 Pine Avenue West, Montreal, QC, Canada H3A 1A1

Received 27 February 2013; Revised 22 April 2013; Accepted 30 April 2013

Academic Editor: Francisco Blanco-Vaca

Copyright © 2013 Anouar Hafiane and Jacques Genest. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [26 citations]

The following is the list of published articles that have cited the current article.

  • G. Klose, and R. Hambrecht, “HDL – „Game over“?,” Der Kardiologe, vol. 7, no. 5, pp. 346–351, 2013. View at Publisher · View at Google Scholar
  • Ki-Chul Sung, Sarah H. Wild, and Christopher D. Byrne, “Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis,” Atherosclerosis, vol. 231, no. 2, pp. 181–186, 2013. View at Publisher · View at Google Scholar
  • Hoyer, “Non-pharmacological and pharmacological treatment of arterial hypertension. Current situation,” Kardiologe, vol. 7, no. 5, pp. 352–361, 2013. View at Publisher · View at Google Scholar
  • Anouar Hafiane, Bashar Jabor, Isabelle Ruel, Jennifer Ling, and Jacques Genest, “High-Density Lipoprotein Mediated Cellular Cholesterol Efflux in Acute Coronary Syndromes,” The American Journal of Cardiology, 2013. View at Publisher · View at Google Scholar
  • Alejandro Gugliucci, and Teresita Menini, “Paraoxonase 1 and HDL maturation,” Clinica Chimica Acta, 2014. View at Publisher · View at Google Scholar
  • Hussein Kalakech, Pierre Hibert, Delphine Prunier-Mirebeau, Sophie Tamareille, Franck Letournel, Laurent Macchi, Florence Pinet, Alain Furber, and Fabrice Prunier, “RISK and SAFE Signaling Pathway Involvement in Apolipoprotein A-I-Induced Cardioprotection,” Plos One, vol. 9, no. 9, 2014. View at Publisher · View at Google Scholar
  • Bronwyn A. Kingwell, M. John Chapman, Anatol Kontush, and Norman E. Miller, “HDL-targeted therapies: progress, failures and future,” Nature Reviews Drug Discovery, 2014. View at Publisher · View at Google Scholar
  • Anouar Hafiane, Samantha Kellett, and Jacques Genest, “Treatment options for low high-density lipoproteins,” Current Opinion in Endocrinology & Diabetes and Obesity, vol. 21, no. 2, pp. 134–139, 2014. View at Publisher · View at Google Scholar
  • R. J. Doonan, A. Hafiane, C. Lai, J. P. Veinot, J. Genest, and S. S. Daskalopoulou, “Cholesterol Efflux Capacity, Carotid Atherosclerosis, and Cerebrovascular Symptomatology,” Arteriosclerosis Thrombosis and Vascular Biology, vol. 34, no. 4, pp. 921–926, 2014. View at Publisher · View at Google Scholar
  • Hakki Yilmaz, Alper Bozkurt, Muzaffer Cakmak, Huseyin Tugrul Celik, Mukadder Ayse Bilgic, Nuket Bavbek, and Ali Akcay, “Relationship between late arteriovenous fistula (AVF) stenosis and neutrophil–lymphocyte ratio (NLR) in chronic hemodialysis patients,” Renal Failure, vol. 36, no. 9, pp. 1390–1394, 2014. View at Publisher · View at Google Scholar
  • Jean Davignon, Michel P. Hermans, Khalid Al-Rubeaan, Pierre Amarenco, Gerd Assmann, Philip Barter, John Betteridge, Eric Bruckert, Ada Cuevas, Michel Farnier, Ele Ferrannini, Paola Fioretto, Jacques Genest, Henry N. Ginsberg, Antonio M. Gotto, Dayi Hu, Takashi Kadowaki, Tatsuhiko Kodama, Michel Krempf, Yuji Matsuzawa, Jesus Millan Nunez-Cortes, Carlos Calvo Monfil, Hisao Ogawa, Jorge Plutzky, Daniel J. Rader, Shaukat Sadikot, Raul D. Santos, Evgeny Shlyakhto, Piyamitr Sritara, Rody Sy, Alan Tall, Chee Eng Tan, Lale Tokgozoglu, Peter P. Toth, Paul Valensi, Christoph Wanner, Alberto Zambon, Junren Zhu, and Paul Zimmet, “Residual macrovascular risk in 2013: what have we learned?,” Cardiovascular Diabetology, vol. 13, 2014. View at Publisher · View at Google Scholar
  • Barbara Cybulska, and Longina Klosiewicz-Latoszek, “The HDL paradox: what does it mean and how to manage low serum HDL cholesterol level?,” Kardiologia Polska, vol. 72, no. 8, pp. 681–686, 2014. View at Publisher · View at Google Scholar
  • Anouar Hafiane, John K. Bielicki, Jan O. Johansson, and Jacques Genest, “Novel apo E-derived ABCA1 agonist peptide (CS-6253) promotes reverse cholesterol transport and induces formation of preβ-1 HDL in vitro,” PLoS ONE, vol. 10, no. 7, 2015. View at Publisher · View at Google Scholar
  • S Skovsø, J Damgaard, J J Fels, G S Olsen, X A Wolf, B Rolin, and J J Holst, “Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes,” International Journal of Obesity, 2015. View at Publisher · View at Google Scholar
  • Daniel I. Swerdlow, Aroon D. Hingorani, and Steve E. Humphries, “Genetic Risk Factors and Mendelian Randomization in Cardiovascular Disease,” Current Cardiology Reports, vol. 17, no. 5, 2015. View at Publisher · View at Google Scholar
  • Sin-Hye Park, Ji Paek, Daekeun Shin, Jae-Yong Lee, Soon Lim, and Young-Hee Kang, “Purple perilla extracts with α-asarone enhance cholesterol efflux from oxidized LDL-exposed macrophages,” International Journal of Molecular Medicine, 2015. View at Publisher · View at Google Scholar
  • Man K S Lee, Xiao-Lei Moore, Yi Fu, Annas Al-Sharea, Dragana Dragoljevic, Manuel A Fernandez-Rojo, Robert Parton, Dmitri Sviridov, Andrew J Murphy, and Jaye P F Chin-Dusting, “High-density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin-1,” British Journal of Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Anouar Hafiane, and Jacques Genest, “High Density Lipoproteins: Measurement Techniques and Potential Biomarkers of Cardiovascular Risk,” BBA Clinical, 2015. View at Publisher · View at Google Scholar
  • Jie Han, Song Zhang, Ping Ye, Yong-Xue Liu, Yan-wen Qin, and Dong-Mei Miao, “Apolipoprotein A-I Mimetic Peptide D-4F Reduces Cardiac Hypertrophy and Improves Apolipoprotein A-I–Mediated Reverse Cholesterol Transport From Cardiac Tissue in LDL Receptor-null Mice Fed a Western Diet,” Journal of Cardiovascular Pharmacology, vol. 67, no. 5, pp. 412–417, 2016. View at Publisher · View at Google Scholar
  • Hong Y. Choi, Anouar Hafiane, Adel Schwertani, and Jacques Genest, “High-Density Lipoproteins: Biology, Epidemiology, and Clinical Management,” Canadian Journal of Cardiology, 2016. View at Publisher · View at Google Scholar
  • Dean Gilham, Sylwia Wasiak, Laura M. Tsujikawa, Christopher Halliday, Karen Norek, Reena G. Patel, Ewelina Kulikowski, Jan Johansson, Michael Sweeney, and Norman C.W. Wong, “RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease,” Atherosclerosis, 2016. View at Publisher · View at Google Scholar
  • Mihaela G. Carnuta, Camelia S. Stancu, Laura Toma, Gabriela M. Sanda, Loredan S. Niculescu, Mariana Deleanu, Andreea C. Popescu, Mihaela R. Popescu, Adelina Vlad, Doina R. Dimulescu, Maya Simionescu, and Anca V. Sima, “Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Barbara Castella, Joanna Kopecka, Patrizia Sciancalepore, Giorgia Mandili, Myriam Foglietta, Nico Mitro, Donatella Caruso, Francesco Novelli, Chiara Riganti, and Massimo Massaia, “The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells,” Nature Communications, vol. 8, pp. 15663, 2017. View at Publisher · View at Google Scholar
  • Eun-Jung Rhee, Christopher D. Byrne, and Ki-Chul Sung, “The HDL cholesterol/apolipoprotein A-I ratio,” Current Opinion in Endocrinology & Diabetes and Obesity, vol. 24, no. 2, pp. 148–153, 2017. View at Publisher · View at Google Scholar
  • Jacques Genest, and Hong Y. Choi, “Novel Approaches for HDL-Directed Therapies,” Current Atherosclerosis Reports, vol. 19, no. 12, 2017. View at Publisher · View at Google Scholar
  • Jiyang Li, Weina Wang, Lei Han, Meiqing Feng, Hui Lu, Li Yang, Xiangxiang Hu, Si Shi, Shanshan Jiang, Qian Wang, and Li Ye, “Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model,” Acta Biochimica et Biophysica Sinica, 2017. View at Publisher · View at Google Scholar